Earnings calendar/CRVS
Corvus Pharmaceuticals, Inc. (CRVS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.21
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.15
Beat rate last 4: 25%
Latest EPS YoY
-90.0%
vs 2025-08-07
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.19 / $-0.16
-19.4%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.21 | Pending | — | — | Pending | — |
| 8/6/2026 | $-0.16 | $-0.19 | -19.4% | — | Pending | — |
| 5/14/2026upcoming | $-0.14 | Pending | — | — | Pending | — |
| 5/7/2026 | $-0.14 | $-0.15 | -7.1% | — | Pending | — |
| 3/24/2026upcoming | $-0.14 | Pending | — | — | Pending | — |
| 3/12/2026 | $-0.14 | $-0.15 | -7.1% | $775,000 | Pending | — |
| 11/4/2025 | $-0.14 | $-0.12 | +14.3% | — | Pending | — |
| 8/7/2025 | $-0.13 | $-0.10 | +23.1% | — | Pending | — |
| 5/8/2025 | $-0.13 | $-0.13 | 0.0% | — | Pending | — |
| 3/25/2025 | $-0.12 | $-0.18 | -50.0% | — | Pending | — |
| 11/12/2024 | $-0.11 | $-0.60 | -445.5% | — | Pending | — |
| 8/6/2024 | $-0.12 | $-0.07 | +41.7% | — | Pending | — |
| 5/6/2024 | $-0.12 | $-0.12 | 0.0% | — | Pending | — |
| 3/19/2024 | $-0.14 | $-0.14 | 0.0% | — | $246,000 | — |
| 11/7/2023 | $-0.16 | $-0.12 | +25.0% | — | Pending | — |
| 8/8/2023 | $-0.14 | $-0.14 | 0.0% | — | Pending | — |
| 5/8/2023 | $-0.16 | $-0.17 | -6.3% | — | Pending | — |
| 3/28/2023 | $0.23 | $-0.21 | -191.3% | — | Pending | — |
| 11/3/2022 | $-0.16 | $-0.32 | -100.0% | — | Pending | — |
| 8/8/2022 | $-0.19 | $-0.18 | +5.3% | — | Pending | — |
| 5/5/2022 | $-0.14 | $-0.18 | -28.6% | — | Pending | — |
| 3/10/2022 | $-0.20 | $-0.20 | 0.0% | — | Pending | — |
| 11/1/2021 | $-0.30 | $-0.24 | +20.0% | — | Pending | — |
| 8/2/2021 | $-0.32 | $-0.28 | +12.5% | — | Pending | — |
| 4/29/2021 | $-0.33 | $-0.34 | -3.0% | — | Pending | — |
| 3/25/2021 | $-0.32 | $-0.35 | -9.4% | — | Pending | — |
| 10/29/2020 | $-0.25 | $-0.33 | -32.0% | — | Pending | — |
| 7/30/2020 | $-0.30 | $-0.36 | -20.0% | — | Pending | — |
| 4/30/2020 | $-0.40 | $-0.44 | -10.0% | — | Pending | — |
| 3/5/2020 | $-0.33 | $-0.38 | -15.2% | — | Pending | — |
| 10/29/2019 | $-0.40 | $-0.37 | +7.5% | — | Pending | — |
| 8/1/2019 | $-0.42 | $-0.44 | -4.8% | — | Pending | — |
| 5/9/2019 | $-0.40 | $-0.40 | 0.0% | — | Pending | — |
| 3/7/2019 | $-0.40 | $-0.36 | +10.0% | — | Pending | — |
| 11/1/2018 | $-0.46 | $-0.36 | +21.7% | — | Pending | — |
| 8/2/2018 | $-0.63 | $-0.40 | +36.5% | — | Pending | — |
| 5/3/2018 | $-0.71 | $-0.63 | +11.3% | — | Pending | — |
| 3/1/2018 | $-0.66 | $-0.58 | +12.1% | — | Pending | — |
| 11/2/2017 | $-0.85 | $-0.62 | +27.1% | — | Pending | — |
| 8/3/2017 | $-0.74 | $-0.73 | +1.4% | — | Pending | — |
| 5/4/2017 | $-0.77 | $-0.79 | -2.6% | — | Pending | — |
| 3/10/2017 | $-0.57 | $-0.55 | +3.5% | — | Pending | — |
| 11/3/2016 | $-0.45 | $-0.51 | -13.3% | — | Pending | — |
| 8/4/2016 | $-0.36 | $-0.43 | -19.4% | — | Pending | — |
| 5/6/2016 | $-1.91 | $-5.39 | -182.2% | — | Pending | — |
| 3/22/2016 | — | $-0.15 | — | — | Pending | — |
| 12/31/2015 | — | $-0.68 | — | — | Pending | — |
| 6/30/2015 | — | $-0.99 | — | — | Pending | — |
| 3/31/2015 | — | $-0.09 | — | — | Pending | — |
| 12/31/2014 | — | $-0.49 | — | — | Pending | — |